Nylöf
Lars Nylöf, Gavle SE
Patent application number | Description | Published |
---|---|---|
20120034126 | STAINLESS AUSTENITIC LOW Ni STEEL ALLOY - An austenitic stainless steel alloy having the following composition in percent of weight (wt %): 0.02≦C≦0.06; Si<1.0; 2.0≦Mn≦6.0; 2.0≦Ni≦4.5; 17≦Cr≦19; 2.0≦Cu≦4.0; 0.15≦N≦0.25; 0≦Mo≦1.0; 0≦W≦0.3; 0≦V≦0.3; 0≦Ti≦0.5; 0≦Al≦1.0; 0≦Nb≦0.5; 0≦Co≦1.0; the balance Fe and normally occurring impurities, wherein the contents of the alloying elements are balanced so that the following conditions are fulfilled: | 02-09-2012 |
Martin Nylöf, Sodertalje SE
Patent application number | Description | Published |
---|---|---|
20090149460 | New Compounds - The present invention provides new compounds of formula Ia and Ib: | 06-11-2009 |
20100137322 | NOVEL N-(8-HETEROARYLTETRAHYDRONAPHTALENE-2YL) OR N-(5-HETEROARYLCHROMANE-3-YL) CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN - The present invention relates to new compounds of formula (I) and to pharmaceutical composition containing said compounds and to the use of said compounds in therapy. The present invention further relates to processes for the preparation of said compounds and to new intermediates useful in the preparation thereof. | 06-03-2010 |
20100286202 | New Compounds - The present invention relates to new compounds | 11-11-2010 |
20130210837 | Compounds and Their Use as BACE Inhibitors - The present invention relates to compounds of formula (I) and their pharmaceutical compositions. In addition, the present invention relates to therapeutic methods for the treatment and/or prevention of Aβ-related pathologies such as Down's syndrome, β-amyloid angiopathy such as but not limited to cerebral amyloid angiopathy or hereditary cerebral hemorrhage, disorders associated with cognitive impairment such as but not limited to MCI (“mild cognitive impairment”), Alzheimer's disease, memory loss, attention deficit symptoms associated with Alzheimer's disease, neurodegeneration associated with diseases such as Alzheimer's disease or dementia including dementia of mixed vascular and degenerative origin, pre-senile dementia, senile dementia and dementia associated with Parkinson's disease, progressive supranuclear palsy or cortical basal degeneration. | 08-15-2013 |
Martin Nylöf, Sodertalje SE
Patent application number | Description | Published |
---|---|---|
20100286202 | New Compounds - The present invention relates to new compounds | 11-11-2010 |
20120165347 | Compounds and their use as BACE Inhibitors - The present invention relates to compounds of formula (I) and their pharmaceutical compositions. In addition, the present invention relates to therapeutic methods for the treatment and/or prevention of Aβ-related pathologies such as Down's syndrome, β-amyloid angiopathy such as but not limited to cerebral amyloid angiopathy or hereditary cerebral hemorrhage, disorders associated with cognitive impairment such as but not limited to MCI (“mild cognitive impairment”), Alzheimer's disease, memory loss, attention deficit symptoms associated with Alzheimer's disease, neurodegeneration associated with diseases such as Alzheimer's disease or dementia including dementia of mixed vascular and degenerative origin, pre-senile dementia, senile dementia and dementia associated with Parkinson's disease, progressive supranuclear palsy or cortical basal degeneration. | 06-28-2012 |
20120238579 | New Compounds 806 - The present invention relates to new compounds of formula (I) and to pharmaceutical composition containing said compounds and to the use of said compounds in therapy. The present invention further relates to processes for the preparation of said compounds and to new intermediates useful in the preparation thereof. | 09-20-2012 |